Spatial working memory or short-term place memory is impaired in schizophrenia. The efficiency of antipsychotic drugs, particularly of typical antipsychotics, on cognitive deficit in schizophrenia remains disputable. Inhibition of serotonin (5-HT) 2A/2C receptors is important for cognitive improvement in schizophrenic patients treated with antipsychotics. The aim of the present work was to establish the effect of the 5-HT2A/2C receptor antagonist ritanserin (2.5 or 5 mg/kg), the dopamine D2 antagonist haloperidol (0.1 or 1 mg/kg), and the atypical antipsychotic risperidone (0.1 mg/kg or 1 mg/kg), which is an antagonist of both 5-HT2A/2C and D2 receptors, on cognitive deficit induced by subchronic administration of dizocilpine (MK-801, 0.1 mg/kg). We used the active allothetic place avoidance (AAPA) task, requiring the rat to differentiate between relevant and irrelevant stimuli, in a way similar to disruption of information processing disturbed in schizophrenic patients. Our results show that treatment with 5-HT2A/2C receptor antagonists, regardless of their effect on D2 receptors, blocked the cognitive impairment produced by MK-801. Haloperidol did not sufficiently reduce the deficit in AAPA induced by MK-801. Interestingly, administration of risperidone and haloperidol alone, but not ritanserin, impaired the AAPA performance in intact rats. Ritanserin and risperidone actually improve cognition independently of their effect on locomotor activity in an animal model of schizophrenia-like behavior. This finding is in accordance with the assumption that some antipsychotics are primarily effective against cognitive dysfunction in schizophrenia.

Department of Brain Pathophysiology and Biochemistry Prague Psychiatric Center 181 03 Prague 8 Czech Republic

Zobrazit více v PubMed

Breier A. Cognitive deficit in schizophrenia and its neurochemical basis. Br J Psychiatry Suppl. 1999;37:16–18. PubMed

Meltzer HY, McGurk SR. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull. 1999;25:233–255. PubMed

Lewis R. Should cognitive deficit be a diagnostic criterion for schizophrenia? J Psychiatry Neurosci. 2004;29:102–113. PubMed PMC

McGurk SR, et al. The effects of clozapine and risperidone on spatial working memory in schizophrenia. Am J Psychiatry. 2005;162:1013–1016. PubMed

Fraser D, Park S, Clark G, Yohanna D, Houk JC. Spatial serial order processing in schizophrenia. Schizophr Res. 2004;70:203–213. PubMed

Glahn DC, et al. Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry. 2003;53:624–626. PubMed

Keefe RS, et al. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: A randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry. 2004;161:985–995. PubMed

Meltzer HY, Li Z, Kaneda Y, Ichikawa J. Serotonin receptors: Their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:1159–1172. PubMed

Jentsch JD, Roth RH. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1999;20:201–225. PubMed

Rujescu D, et al. A pharmacological model for psychosis based on N-methyl-d[scap][r]-aspartate receptor hypofunction: Molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry. 2006;59:721–729. PubMed

Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology. 2001;156:117–154. PubMed

Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301–1308. PubMed

Carlsson A, et al. Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence. Annu Rev Pharmacol Toxicol. 2001;41:237–260. PubMed

Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R. Study of a new schizophrenomimetic drug, sernyl. AMA Arch Neurol Psychiatry. 1959;81:363–369. PubMed

Stuchlik A, Rezacova L, Vales K, Bubenikova V, Kubik S. Application of a novel active allothetic place avoidance task (AAPA) in testing a pharmacological model of psychosis in rats: Comparison with the Morris water maze. Neurosci Lett. 2004;366:162–166. PubMed

Vales K, Bubenikova-Valesova V, Klement D, Stuchlik A. Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris water maze reveals differences between Long–Evans and Wistar rats. Neurosci Res. 2006;55:383–388. PubMed

Schwartz BD, Tomlin HR, Evans WJ, Ross KV. Neurophysiologic mechanisms of attention: A selective review of early information processing in schizophrenics. Front Biosci. 2001;6:120–134. PubMed

Light GA, Braff DL. Human and animal studies of schizophrenia-related gating deficits. Curr Psychiatry Rep. 1999;1:31–40. PubMed

Abdul-Monim Z, Neill JC, Reynolds GP. Subchronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol. 2007;21:198–205. PubMed

Dunn MJ, Killcross S. Clozapine but not haloperidol treatment reverses subchronic phencyclidine-induced disruption of conditional discrimination performance. Behav Brain Res. 2006;175:271–277. PubMed

He J, et al. The effects of chronic administration of quetiapine on the phencyclidine-induced reference memory impairment and decrease of Bcl-X. Behav Brain Res. 2006;168:236–242. PubMed

Amitai N, Semenova S, Markou A. Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats. Psychopharmacology. 2007;193:521–537. PubMed

Skarsfeldt T. Differential effect of antipsychotics on place navigation of rats in the Morris water maze: A comparative study between novel and reference antipsychotics. Psychopharmacology. 1996;124:126–133. PubMed

Rosengarten H, Quartermain D. The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and 18-month-old rats. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:1047–1054. PubMed

Gemperle AY, McAllister KH, Olpe HR. Differential effects of iloperidone, clozapine, and haloperidol on working memory of rats in the delayed non-matching-to-position paradigm. Psychopharmacology. 2003;169:354–364. PubMed

Wolff MC, Leander JD. Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. Psychopharmacology. 2003;168:410–416. PubMed

Didriksen M, Kreilgaard M, Arnt J. Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment. Eur J Pharmacol. 2006;542:108–115. PubMed

Hou Y, Wu CF, Yang JY, Guo T. Differential effects of haloperidol, clozapine, and olanzapine on learning and memory functions in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1486–1495. PubMed

Ahlander M, Misane I, Schott PA, Ogren SO. A behavioral analysis of the spatial learning deficit induced by the NMDA receptor antagonist MK-801 (dizocilpine) in the rat. Neuropsychopharmacology. 1999;21:414–426. PubMed

Horacek J, et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs. 2006;20:389–409. PubMed

Addy N, Levin ED. Nicotine interactions with haloperidol, clozapine, and risperidone and working memory function in rats. Neuropsychopharmacology. 2002;27:534–541. PubMed

Lipska BK, Weinberger DR. To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology. 2000;23:223–239. PubMed

Addy NA, Pocivavsek A, Levin ED. Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions. Neuropsychopharmacology. 2005;30:1121–1127. PubMed

Varty GB, Bakshi VP, Geyer MA. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague–Dawley and Wistar rats. Neuropsychopharmacology. 1999;20:311–321. PubMed

Csernansky JG, et al. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology. 2005;30:2135–2143. PubMed PMC

Stip E, Lussier I. The effect of risperidone on cognition in patients with schizophrenia. Can J Psychiatry. 1996;41:S35–S40. PubMed

Green MF, et al. Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry. 1997;154:799–804. PubMed

Cimadevilla JM, Kaminsky Y, Fenton A, Bures J. Passive and active place avoidance as a tool of spatial memory research in rats. J Neurosci Methods. 2000;102:155–164. PubMed

Wesierska M, Dockery C, Fenton AA. Beyond memory, navigation, and inhibition: Behavioral evidence for hippocampus-dependent cognitive coordination in the rat. J Neurosci. 2005;25:2413–2419. PubMed PMC

Drugs Interfering with Muscarinic Acetylcholine Receptors and Their Effects on Place Navigation

Acute administration of MK-801 in an animal model of psychosis in rats interferes with cognitively demanding forms of behavioral flexibility on a rotating arena

Nogo-A-deficient Transgenic Rats Show Deficits in Higher Cognitive Functions, Decreased Anxiety, and Altered Circadian Activity Patterns

MK-801 Impairs Cognitive Coordination on a Rotating Arena (Carousel) and Contextual Specificity of Hippocampal Immediate-Early Gene Expression in a Rat Model of Psychosis

Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats